Abstract

BackgroundDrug allergy represent an important subset of adverse drug reactions that is worthy of attention because many of these reactions are potentially preventable with use of computerised decision support systems. This is however dependent on the accurate and comprehensive recording of these reactions in the electronic health record. The objectives of this study were to understand approaches to the recording of drug allergies in electronic health record systems.Materials and MethodsWe undertook a case study comprising of 21 in-depth interviews with a purposefully selected group of primary and secondary care clinicians, academics, and members of the informatics and drug regulatory communities, observations in four General Practices and an expert group discussion with 15 participants from the Allergy and Respiratory Expert Resource Group of the Royal College of General Practitioners.ResultsThere was widespread acceptance among healthcare professionals of the need for accurate recording of drug allergies and adverse drug reactions. Most drug reactions were however likely to go unreported to and/or unrecognised by healthcare professionals and, even when recognised and reported, not all reactions were accurately recorded. The process of recording these reactions was not standardised.ConclusionsThere is considerable variation in the way drug allergies are recorded in electronic health records. This limits the potential of computerised decision support systems to help alert clinicians to the risk of further reactions. Inaccurate recording of information may in some instances introduce new problems as patients are denied treatments that they are erroneously believed to be allergic to.

Highlights

  • Adverse drug reactions are very common [1]; they for example, account for an estimated 6.5% of hospital admissions in the United Kingdom (UK) [2]

  • Clinical computerised decision support systems (CDSS) in prescribing modules are widely seen as having considerable potential to reduce the risk of allergic reactions to drugs by drawing on information held in electronic health records (EHRs) to generate tailored alerts in real-time [5,6,7]

  • Five key themes emerged from analysis of our data, namely the: (1) diverse approaches to recording of drug allergies; (2) variable extent of recording; (3) perceived benefits of recording; (4) perceived risks of recording such information; and (5) the wider contextual considerations including the training of professionals, incentives and secondary uses of data

Read more

Summary

Introduction

Adverse drug reactions are very common [1]; they for example, account for an estimated 6.5% of hospital admissions in the United Kingdom (UK) [2]. Clinical computerised decision support systems (CDSS) in prescribing modules are widely seen as having considerable potential to reduce the risk of allergic reactions to drugs by drawing on information held in electronic health records (EHRs) to generate tailored alerts in real-time [5,6,7]. Drug allergy represent an important subset of adverse drug reactions that is worthy of attention because many of these reactions are potentially preventable with use of computerised decision support systems This is dependent on the accurate and comprehensive recording of these reactions in the electronic health record. The objectives of this study were to understand approaches to the recording of drug allergies in electronic health record systems

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.